Die Studie ist in Englisch. Um Teil zu nehmen, müssen Sie der englischen oder holländischen Sprache mächtig sein.
- Mann oder Frau
- 18-64 jaar
Study of a new compound that is being developed for the treatment of diseases of the immune system.
As a male, you can only participate in this study if until 90 days after receiving the last trial medication, you:
As a female, you can only participate in this study if you:
For the C-groups, the study consists of 2 periods, during which you will stay in our research facility in Groningen for 5 days (4 nights) for each period. After the 2nd period a follow-up visit will take place, 2 to 6 days after your discharge from the research facility. This follow-up is a visit to the research facility of a couple of hours. The appointment for your follow-up visit will be made during your stay.
NOTE: You must be available for all specified dates to be able to participate in this study. The current dates of the study are available on our website. These are the currently planned dates; however, these may be subject to change.
Travel expenses will be reimbursed based on the distance traveled (€0.19 net per kilometer) with a minimum of €12 and a maximum of €160 (840 kilometers) per round trip, regardless of the mode of transportation.